BIMI International Medical Inc.
BIMI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $2,523 | $5,558 | $3,198 | -$5,432 |
| % Growth | -54.6% | 73.8% | 158.9% | – |
| Cost of Goods Sold | $2,408 | $2,674 | $1,507 | -$3,113 |
| Gross Profit | $115 | $2,884 | $1,690 | -$7,750 |
| % Margin | 4.6% | 51.9% | 52.8% | 142.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,093 | $1,348 | $853 | $967 |
| SG&A Expenses | $3,265 | $1,585 | $1,109 | $3,025 |
| Sales & Mktg Exp. | $172 | $236 | $256 | -$1,261 |
| Other Operating Expenses | $0 | $0 | $0 | -$576 |
| Operating Expenses | $3,265 | $1,585 | $1,109 | $5,092 |
| Operating Income | -$3,150 | $1,299 | $581 | -$7,411 |
| % Margin | -124.9% | 23.4% | 18.2% | 136.4% |
| Other Income/Exp. Net | $16 | -$125 | -$1,441 | -$3,641 |
| Pre-Tax Income | -$3,134 | $1,174 | -$861 | -$11,051 |
| Tax Expense | $0 | $0 | $0 | -$24 |
| Net Income | -$3,129 | $1,054 | -$884 | -$11,796 |
| % Margin | -124% | 19% | -27.6% | 217.2% |
| EPS | -0.49 | 0.23 | -0.23 | -4.14 |
| % Growth | -313% | 200% | 94.4% | – |
| EPS Diluted | -0.49 | 0.23 | -0.23 | -4.14 |
| Weighted Avg Shares Out | 6,430 | 4,596 | 3,834 | 2,665 |
| Weighted Avg Shares Out Dil | 6,430 | 4,596 | 3,834 | 2,665 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $36 | $35 | $35 | $3,115 |
| Depreciation & Amortization | -$17 | $74 | $54 | $58 |
| EBITDA | -$3,098 | $1,284 | -$772 | -$7,879 |
| % Margin | -122.8% | 23.1% | -24.1% | 145% |